Cohance Lifesciences Ltd.

₹979.35

Cohance Lifesciences Ltd.

Add Alert
Add Watchlist

₹979.35

₹979.35

-19.1 (-1.91%) - 2 Aug 2025 04:28 PM

About Company

Suven Pharmaceuticals Limited is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Market Cap. ₹ 37,467 Cr.
52 Week - High/Low ₹ 1,360/916
P/E Ratio 91.61
P/B Ratio 18.22
Enterprise Value -
ROE % 16.03
RSI Value 12.82
EMA 50 1061.96
EMA 200 1077.4
Market Cap. ₹ 37,467 Cr.
52 Week - High/Low ₹ 1,360/916
P/E Ratio 93.01
P/B Ratio 18.27
Enterprise Value -
ROE % 15.87
RSI Value 12.82
EMA 50 1061.96
EMA 200 1077.4

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.